BRCA1 and ovarian cancer: This phenomenon is well documented in the cases of recurrent chemoresistant ovarian cancer which has been shown to reacquire DNA repair proficiency by reversion of BRCA1/BRCA2 mutations or modification of epigenetic marks [58,59].